Pre-clinical evaluation of snake venom proteins with therapeutic potential. Australia harbors some of the most toxic snakes in the world. Their venoms contain a range of substances that are designed to rapidly immobilize and kill their prey. These include agents that lead to enhanced blood clotting; excess bleeding. We have isolated and characterized a large number of the components involved over the last several years. The aim here is to carry out pre-clinical trials in animal models to test th ....Pre-clinical evaluation of snake venom proteins with therapeutic potential. Australia harbors some of the most toxic snakes in the world. Their venoms contain a range of substances that are designed to rapidly immobilize and kill their prey. These include agents that lead to enhanced blood clotting; excess bleeding. We have isolated and characterized a large number of the components involved over the last several years. The aim here is to carry out pre-clinical trials in animal models to test the efficacy of three proteins as anti-bleeding agents and investigate several other novel components. The ultimate outcome will be the development of novel drugs that will have application in the treatment of human disorders. Read moreRead less
Regulating Medical Nanotechnology in Australia: Developing Practical Improvements in Safety and Cost-Effectiveness Analysis. This Project will provide policy makers with previously unavailable detailed information and well developed, innovative regulatory options, on how best to ensure safe and cost-effective use of one of the fastest growing areas of Australian research and development: medical nanotechnology. The Project will benefit Australian healthcare workers and patients who will increasi ....Regulating Medical Nanotechnology in Australia: Developing Practical Improvements in Safety and Cost-Effectiveness Analysis. This Project will provide policy makers with previously unavailable detailed information and well developed, innovative regulatory options, on how best to ensure safe and cost-effective use of one of the fastest growing areas of Australian research and development: medical nanotechnology. The Project will benefit Australian healthcare workers and patients who will increasingly be exposed to, and concerned about, the risks of medical nanotechnology. It will help to facilitate export and institutional uptake of Australian medical nanotechnology products, by ensuring they comply with world's best practise safety standards and offer value for public expenditure. Read moreRead less